Literature DB >> 1362724

Inhibitory NANC nerves in human tracheal smooth muscle: a quest for the neurotransmitter.

M G Belvisi1, C D Stretton, M Miura, G M Verleden, S Tadjkarimi, M H Yacoub, P J Barnes.   

Abstract

Inhibitory nonadrenergic noncholinergic (i-NANC) nerves are the only neural bronchodilator pathway in human airways. Possible candidates for the neurotransmitter include vasoactive intestinal peptide (VIP) and nitric oxide (NO) and purines such as ATP. We have investigated the potential role of these neurotransmitters. Phosphoramidon (10(-5) M) significantly potentiated relaxations to low doses of VIP with no effect on i-NANC responses. Relaxations induced by VIp were abolished with alpha-chymotrypsin (2 U/ml), but i-NANC responses were unaffected. Reactive blue 2 had no effect on i-NANC neural responses, indicating that endogenous ATP was not involved. The NO synthase inhibitor L-NG-nitroarginine methyl ester (L-NAME, 10(-4) M) produced a concentration-dependent inhibition of the i-NANC response, producing almost complete inhibition at every frequency studied (0.5-40 Hz), whereas L-NG-monomethyl arginine was effective only at low stimulation frequencies. The inhibitory effect of L-NAME was partially reversed by L- but not D-arginine, and D-NAME was without effect. These results suggest that in human tracheal segments the neural bronchodilator response is mediated by NO, and there is no functional evidence for implicating VIP in this response.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1362724     DOI: 10.1152/jappl.1992.73.6.2505

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  11 in total

1.  YC-1 potentiates nitric oxide-induced relaxation in guinea-pig trachea.

Authors:  T L Hwang; C C Wu; C M Teng
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

2.  Characterization of non-adrenergic, non-cholinergic inhibitory responses of the isolated guinea-pig trachea: differences between pre- and post-ganglionic nerve stimulation.

Authors:  J D Moffatt; B Dumsday; J R McLean
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

Review 3.  Management of acute pediatric asthma.

Authors:  John C Carl; Carolyn M Kercsmar
Journal:  Curr Allergy Asthma Rep       Date:  2002-11       Impact factor: 4.806

4.  Role of carbon monoxide in electrically induced non-adrenergic, non-cholinergic relaxations in the guinea-pig isolated whole trachea.

Authors:  A Dellabianca; M Sacchi; L Anselmi; E De Amici; E Cervio; A Agazzi; S Tonini; C Sternini; M Tonini; S M Candura
Journal:  Br J Pharmacol       Date:  2006-12-18       Impact factor: 8.739

Review 5.  Nitric oxide and lung disease.

Authors:  P J Barnes; M G Belvisi
Journal:  Thorax       Date:  1993-10       Impact factor: 9.139

6.  Multiple calcium channels regulate neurotransmitter release from vagus nerve terminals in the cat bronchiole.

Authors:  K Fujisawa; H Onoue; K Abe; Y Ito
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

7.  Modulation of cholinergic neural bronchoconstriction by endogenous nitric oxide and vasoactive intestinal peptide in human airways in vitro.

Authors:  J K Ward; M G Belvisi; A J Fox; M Miura; S Tadjkarimi; M H Yacoub; P J Barnes
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

8.  Regional difference in the distribution of L-NAME-sensitive and -insensitive NANC relaxations in cat airway.

Authors:  N Takahashi; H Tanaka; N Abdullah; L Jing; R Inoue; Y Ito
Journal:  J Physiol       Date:  1995-11-01       Impact factor: 5.182

9.  Evidence for the involvement of cGMP in neural bronchodilator responses in humal trachea.

Authors:  J K Ward; P J Barnes; S Tadjkarimi; M H Yacoub; M G Belvisi
Journal:  J Physiol       Date:  1995-03-01       Impact factor: 5.182

10.  Role of nitric oxide in non-adrenergic, non-cholinergic relaxation and modulation of excitatory neuroeffector transmission in the cat airway.

Authors:  L Jing; R Inoue; K Tashiro; S Takahashi; Y Ito
Journal:  J Physiol       Date:  1995-02-15       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.